Karen E Bascom1, John Dziodzio2, Samip Vasaiwala1, Michael Mooney3, Nainesh Patel4, John McPherson5, Paul McMullan6, Barbara Unger7, Niklas Nielsen8,9, Hans Friberg8,10, Richard R Riker2, Karl B Kern11, Christine W Duarte12, David B Seder13. 1. Departments of Cardiology (K.E.B., S.V.). 2. Critical Care Services, Maine Medical Center, Portland (J.D., R.R.R., D.B.S.). 3. Department of Cardiology, Abbott Northwestern Hospital, Minneapolis, MN (M.M.). 4. Division of Cardiology, Lehigh Valley Health Network, Allentown, PA (N.P.). 5. Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (J.M.). 6. St Thomas Heart, Nashville, TN (P.M.). 7. Minneapolis Heart Institute, MN (B.U.). 8. Department of Clinical Sciences, Lund University, Sweden (N.N., H.F.). 9. Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Sweden (N.N.). 10. Department of Perioperative and Intensive Care, Skåne University Hospital, Lund, Sweden (H.F.). 11. Division of Cardiology, Sarver Heart Center, University of Arizona, Tucson (K.B.K.). 12. Maine Medical Center Research Institute, Scarborough (C.W.D.). 13. Critical Care Services, Maine Medical Center, Portland (J.D., R.R.R., D.B.S.) sederd@mmc.org.
Abstract
BACKGROUND: No practical tool quantitates the risk of circulatory-etiology death (CED) immediately after successful cardiopulmonary resuscitation in patients without ST-segment-elevation myocardial infarction. We developed and validated a prediction model to rapidly determine that risk and facilitate triage to individualized treatment pathways. METHODS: With the use of INTCAR (International Cardiac Arrest Registry), an 87-question data set representing 44 centers in the United States and Europe, patients were classified as having had CED or a combined end point of neurological-etiology death or survival. Demographics and clinical factors were modeled in a derivation cohort, and backward stepwise logistic regression was used to identify factors independently associated with CED. We demonstrated model performance using area under the curve and the Hosmer-Lemeshow test in the derivation and validation cohorts, and assigned a simplified point-scoring system. RESULTS: Among 638 patients in the derivation cohort, 121 (18.9%) had CED. The final model included preexisting coronary artery disease (odds ratio [OR], 2.86; confidence interval [CI], 1.83-4.49; P≤0.001), nonshockable rhythm (OR, 1.75; CI, 1.10-2.77; P=0.017), initial ejection fraction<30% (OR, 2.11; CI, 1.32-3.37; P=0.002), shock at presentation (OR, 2.27; CI, 1.42-3.62; P<0.001), and ischemic time >25 minutes (OR, 1.42; CI, 0.90-2.23; P=0.13). The derivation model area under the curve was 0.73, and Hosmer-Lemeshow test P=0.47. Outcomes were similar in the 318-patient validation cohort (area under the curve 0.68, Hosmer-Lemeshow test P=0.41). When assigned a point for each associated factor in the derivation model, the average predicted versus observed probability of CED with a CREST score (coronary artery disease, initial heart rhythm, low ejection fraction, shock at the time of admission, and ischemic time >25 minutes) of 0 to 5 was: 7.1% versus 10.2%, 9.5% versus 11%, 22.5% versus 19.6%, 32.4% versus 29.6%, 38.5% versus 30%, and 55.7% versus 50%. CONCLUSIONS: The CREST model stratified patients immediately after resuscitation according to risk of a circulatory-etiology death. The tool may allow for estimation of circulatory risk and improve the triage of survivors of cardiac arrest without ST-segment-elevation myocardial infarction at the point of care.
BACKGROUND: No practical tool quantitates the risk of circulatory-etiology death (CED) immediately after successful cardiopulmonary resuscitation in patients without ST-segment-elevation myocardial infarction. We developed and validated a prediction model to rapidly determine that risk and facilitate triage to individualized treatment pathways. METHODS: With the use of INTCAR (International Cardiac Arrest Registry), an 87-question data set representing 44 centers in the United States and Europe, patients were classified as having had CED or a combined end point of neurological-etiology death or survival. Demographics and clinical factors were modeled in a derivation cohort, and backward stepwise logistic regression was used to identify factors independently associated with CED. We demonstrated model performance using area under the curve and the Hosmer-Lemeshow test in the derivation and validation cohorts, and assigned a simplified point-scoring system. RESULTS: Among 638 patients in the derivation cohort, 121 (18.9%) had CED. The final model included preexisting coronary artery disease (odds ratio [OR], 2.86; confidence interval [CI], 1.83-4.49; P≤0.001), nonshockable rhythm (OR, 1.75; CI, 1.10-2.77; P=0.017), initial ejection fraction<30% (OR, 2.11; CI, 1.32-3.37; P=0.002), shock at presentation (OR, 2.27; CI, 1.42-3.62; P<0.001), and ischemic time >25 minutes (OR, 1.42; CI, 0.90-2.23; P=0.13). The derivation model area under the curve was 0.73, and Hosmer-Lemeshow test P=0.47. Outcomes were similar in the 318-patient validation cohort (area under the curve 0.68, Hosmer-Lemeshow test P=0.41). When assigned a point for each associated factor in the derivation model, the average predicted versus observed probability of CED with a CREST score (coronary artery disease, initial heart rhythm, low ejection fraction, shock at the time of admission, and ischemic time >25 minutes) of 0 to 5 was: 7.1% versus 10.2%, 9.5% versus 11%, 22.5% versus 19.6%, 32.4% versus 29.6%, 38.5% versus 30%, and 55.7% versus 50%. CONCLUSIONS: The CREST model stratified patients immediately after resuscitation according to risk of a circulatory-etiology death. The tool may allow for estimation of circulatory risk and improve the triage of survivors of cardiac arrest without ST-segment-elevation myocardial infarction at the point of care.
Authors: Timothy N Jones; Matthew Kelham; Krishnaraj S Rathod; Charles J Knight; Alastair Proudfoot; Ajay K Jain; Andrew Wragg; Muhiddin Ozkor; Paul Rees; Oliver Guttmann; Andreas Baumbach; Anthony Mathur; Daniel A Jones Journal: Am J Cardiovasc Dis Date: 2021-12-15
Authors: Maria Trepa; Samuel Bastos; Marta Fontes-Oliveira; Ricardo Costa; André Dias-Frias; André Luz; Vasco Dias; Mário Santos; Severo Torres Journal: J Crit Care Med (Targu Mures) Date: 2020-01-31
Authors: Joachim Düring; Martin Annborn; Tobias Cronberg; Josef Dankiewicz; Yvan Devaux; Christian Hassager; Janneke Horn; Jesper Kjaergaard; Michael Kuiper; Homa Rafi Nikoukhah; Pascal Stammet; Johan Undén; Michael Jaeger Wanscher; Matt Wise; Hans Friberg; Niklas Nielsen Journal: Crit Care Date: 2020-04-28 Impact factor: 9.097
Authors: Lili Ge; Guangquan Liu; Kai Hu; Ke Huang; Mi Zhang; Juan Zhou; Fang Teng; Jian Cao; Chencheng Dai; Xuemei Jia Journal: Technol Cancer Res Treat Date: 2020 Jan-Dec
Authors: Richard T Carrick; Jinny G Park; Hannah L McGinnes; Christine Lundquist; Kristen D Brown; W Adam Janes; Benjamin S Wessler; David M Kent Journal: J Am Heart Assoc Date: 2020-08-13 Impact factor: 5.501
Authors: Pedro Kurtz; Christian Storm; Marcio Soares; Fernando Bozza; Carolina B Maciel; David M Greer; Leonardo S L Bastos; Ulisses Melo; Bruno Mazza; Marcelo S Santino; Roberto Seabra Lannes; Ana Paula Pierre de Moraes; Joel Tavares Passos; Giulliana Martines Moralez; Robson Correa Santos; Maristela Medeiros Machado; Saulo Fernandes Saturnino; Ciro Leite Mendes; Arthur Oswaldo Vianna; Jorge Salluh Journal: Crit Care Explor Date: 2021-07-14